Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2036925 | 0.88 | VRK1 (0.33) | — | |
| SCHEMBL9938339 | 0.86 | — | — | |
| SCHEMBL15525340 | 0.83 | RIPK1 (0.31) | — | |
| SCHEMBL18579909 | 0.82 | — | — | |
| SCHEMBL18580703 | 0.82 | — | — | |
| SCHEMBL17112790 | 0.80 | HSD17B1 (0.34) | — | |
| SCHEMBL18706327 | 0.79 | — | — | |
| SCHEMBL486017 | 0.79 | ALDH1A1 (0.35) | — | |
| SCHEMBL18580552 | 0.77 | TRIM24 (0.30) | — | |
| SCHEMBL16734984 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117486916-B | Synthesis method of 3,4, 5-trifluoro-phenylboronic acid | 山东国邦药业有限公司 | 2024-04-12 | — | — | CN | claimed |
| CN-117486916-A | Synthesis method of 3,4, 5-trifluoro-phenylboronic acid | 山东国邦药业有限公司 | 2024-02-02 | — | — | CN | claimed |
| EP-4522606-A1 | INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS | Merck Sharp & Dohme LLC (US) | 2025-03-19 | — | — | EP | disclosed |
| CN-117486916-B | Synthesis method of 3,4, 5-trifluoro-phenylboronic acid | 山东国邦药业有限公司 | 2024-04-12 | — | — | CN | disclosed |
| CN-117486916-A | Synthesis method of 3,4, 5-trifluoro-phenylboronic acid | 山东国邦药业有限公司 | 2024-02-02 | — | — | CN | disclosed |
| WO-2023220223-A1 | INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS | MERCK SHARP & DOHME LLC (US) | 2023-11-16 | — | — | WO | disclosed |
| US-20230365531-A1 | INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMO VIRUS | MERCK SHARP & DOHME LLC (US) | 2023-11-16 | — | — | US | disclosed |
| CN-116444499-A | Phenylalanine derivative containing 4-quinazolinone and preparation method and application thereof | 山东大学 | 2023-07-18 | — | — | CN | disclosed |
| US-8637710-B2 | Catalyst for cross-coupling reaction comprising unsubstituted or substituted bisphosphinobenzenes | KYOTO UNIVERSITY (JP) | 2014-01-28 | — | — | US | disclosed |
| US-20110152523-A1 | CATALYST FOR CROSS-COUPLING REACTION, AND PROCESS FOR PRODUCTION OF AROMATIC COMPOUND USING THE SAME | KYOTO UNIVERSITY (JP) | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230365531-A1 | INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMO VIRUS | METAP1, SARS1, RTF1 | MEN1 1635/4885KMT2A 3118/4885 |
| US-20110152523-A1 | CATALYST FOR CROSS-COUPLING REACTION, AND PROCESS FOR PRODUCTION OF AROMATIC COMPOUND USING THE SAME | AHR, AR, HRH2 | MEN1 452/4885KMT2A 1095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.